• Association of Longitudinal High-Sensitivity Troponin T with mortality in patients with chronic kidney diseaseChesnaye, Nicholas C.; Al-Sodany, Ehab; Szummer, Karolina; Barany, Peter; Heimbürger, Olof; Almquist, Tora; Melander, Stefan; Uhlin, Nils Fredrik Arne; Dekker, Friedo; Wanner, Christoph; Jager, Kitty J.; Evans, MarieJournal of the American College of Cardiology2022 / p. 327-336 : ill https://doi.org/10.1016/j.jacc.2021.11.023 https://www.scopus.com/sourceid/22401 https://www.scopus.com/record/display.uri?eid=2-s2.0-85122688147&origin=inward&txGid=ad35752a14529204c1af133aaf08cc6a https://jcr.clarivate.com/jcr-jp/journal-profile?journal=J%20AM%20COLL%20CARDIOL&year=2022 https://www.webofscience.com/wos/woscc/full-record/WOS:000752534400005
• Effects of alirocumab on cardiovascular events after coronary bypass surgeryGoodman, Shaun G.; Aylward, Philip E.; Szarek, Michael; Viigimaa, MargusJournal of the American College of Cardiology2019 / p. 1177−1186 : ill https://doi.org/10.1016/j.jacc.2019.07.015
• Lipoprotein(a) and Benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterolSchwartz, Gregory G.; Szarek, Michael; Bittner, Vera A.; Diaz, Rafael; Goodman, Shaun G.; Viigimaa, MargusJournal of the American College of Cardiology2021 / p. 421–433 : ill https://www.jacc.org/doi/epdf/10.1016/j.jacc.2021.04.102 https://doi.org/10.1016/j.jacc.2021.04.102